Lepu Medical: Announcement of Resolutions of the 17th Meeting of the 6th Board of Directors
Securities code: 300003 Securities abbreviation: Lepu Medical Announcement number: 2025-089 Bond code: 123108 Bond abbreviation: Lepu Zhuan 2
Lepu (Beijing) Medical Equipment Co., Ltd.
Announcement of Resolutions of the 17th Meeting of the 6th Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The 17th meeting of the sixth board of directors of Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as the company) was held on September 15, 2025, in the company conference room at No. 37 Chaoqian Road, Changping District, Beijing, in a combination of on-site and communication methods. The meeting notice was notified to all directors by email or telephone on September 8, 2025. Seven directors should be present at the meeting, and 7 directors were actually present, including 5 directors who attended the meeting by voting by communication. This meeting was held in compliance with the relevant provisions of the Company Law and the Articles of Association. The meeting was chaired by Chairman Pu Zhongjie. The directors present at the meeting reviewed and voted by registered vote to adopt the following resolutions:
Consideration of the "Proposal on Not Revising the Conversion Price of "Lepu Zhuan 2" Downward"
According to the relevant provisions of the "Prospectus for the GEM Issuance of Convertible Corporate Bonds to Unspecified Targets by Lepu (Beijing) Medical Equipment Co., Ltd.", as of September 15, 2025, the closing price of the company's stock on at least fifteen trading days out of any thirty consecutive trading days was lower than 80% of the current conversion price.
The company's board of directors comprehensively considers the company's current basic situation, stock price trends, market environment and other factors, as well as its confidence in the company's long-term stable development and intrinsic value. In order to safeguard the interests of all investors and clarify investor expectations, the company's board of directors decided not to downwardly revise the "Lepu Transfer 2" conversion price this time, and within 2 months from the day after the board of directors' approval (i.e. September 16, 2025 to November 15, 2025), if the "Lepu Transfer 2" is triggered again 2" Clause for downward revision of the share conversion price, and no downward revision plan is proposed. Starting from November 16, 2025, if the downward revision clause of the "Lepu Zhuan 2" conversion price is triggered again, the company's board of directors will convene another meeting to decide whether to exercise the right to downward revision of the "Lepu Zhuan 2" conversion price.
For details, please refer to the "Announcement on Not Revising the Conversion Price of "Lepu Zhuan 2" Downward" (announcement number: 2025-090) disclosed on the Juchao Information Network (http://www.cninfo.com.cn) on the same day.
It was passed with 7 votes in favor, 0 votes against, and 0 abstentions.
Announcement is hereby made.
Board of Directors of Lepu (Beijing) Medical Devices Co., Ltd.
September 15, 2025